SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-006330
Filing Date
2018-03-05
Accepted
2018-03-05 16:05:25
Documents
1
Period of Report
2018-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7804
  Complete submission text file 0000899243-18-006330.txt   9291
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Issuer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address AIMMUNE THERAPEUTICS, INC. 8000 MARINA BOULEVARD, SUITE 300 BRISBANE CA 94005
Business Address
Rozenman Mary M. (Reporting) CIK: 0001648920 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37519 | Film No.: 18666021